Results from the phase 3, randomized, double-blind, placebo-controlled OPTIMAL study of oral octreotide capsules in adult patients with acromegaly

Endocrine Abstracts ◽

10.1530/endoabs.70.oc4.6 ◽

2020 ◽

Author(s):

Susan Samson ◽

Lisa Nachtigall ◽

Maria Fleseriu ◽

Murray Gordon ◽

William Ludlam ◽

...

Keyword(s):

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Analysis of adverse events in adult patients with acromegaly receiving oral octreotide capsules: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

Endocrine Abstracts ◽

10.1530/endoabs.70.aep613 ◽

2020 ◽

Author(s):

Artak Labadzhyan ◽

Susan Samson ◽

Lisa Nachtigall ◽

Maria Fleseriu ◽

Mark E Molitch ◽

...

Keyword(s):

Adverse Events ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

Endocrine Abstracts ◽

10.1530/endoabs.70.aep668 ◽

2020 ◽

Author(s):

Lisa Nachtigall ◽

Susan Samson ◽

Maria Fleseriu ◽

Marek Bolanowski ◽

Molitch Mark E ◽

...

Keyword(s):

Somatostatin Receptor ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Receptor Ligand ◽

Double Blind Placebo ◽

Long Acting ◽

Somatostatin Receptor Ligand

Download Full-text

Safety of Specifically Targeting Interleukin 13 with Tralokinumab in Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.11 ◽

2021 ◽

Vol 5 (1) ◽

pp. s11

Author(s):

Eric Simpson ◽

Joseph Merola ◽

Jonathan Silverberg ◽

Rebecca Zachariae ◽

Rebecca Olsen ◽

...

Keyword(s):

Atopic Dermatitis ◽

Pooled Analysis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Phase 2 ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Abstract not available.

Download Full-text

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Trials ◽

10.1186/s13063-020-04352-9 ◽

2020 ◽

Vol 21 (1) ◽

Author(s):

Yeming Wang ◽

Fei Zhou ◽

Dingyu Zhang ◽

Jianping Zhao ◽

Ronghui Du ◽

...

Keyword(s):

Study Protocol ◽

Multicentre Trial ◽

Adult Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1, EVOLVE‐2, and REGAIN Studies

Headache The Journal of Head and Face Pain ◽

10.1111/head.13684 ◽

2019 ◽

Vol 60 (1) ◽

pp. 110-123 ◽

Author(s):

Tina M. Oakes ◽

Richard Kovacs ◽

Noah Rosen ◽

Erin Doty ◽

Phebe Kemmer ◽

...

Keyword(s):

Chronic Migraine ◽

Cardiovascular Outcomes ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Poster 22 OnabotulinumtoxinA Treatment in Adult Patients with Post-Stroke Lower Limb Spasticity: Results from a Double-Blind, Placebo-Controlled, Phase 3 Clinical Trial

PM&R ◽

10.1016/j.pmrj.2015.06.063 ◽

2015 ◽

Vol 7 ◽

pp. S98-S99

Author(s):

Alberto Esquenazi ◽

Theodore Wein ◽

Wolfgang H. Jost ◽

Anthony B. Ward ◽

Tinna Kwan

Keyword(s):

Clinical Trial ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Stroke ◽

Limb Spasticity ◽

Lower Limb Spasticity

Download Full-text

Neutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.56 ◽

2021 ◽

Vol 5 (6) ◽

pp. s56

Author(s):

Thomas Bieber ◽

Lisa Beck ◽

Andrew Pink ◽

Hidehisa Saeki ◽

Lawrence Eichenfeld ◽

...

Keyword(s):

Atopic Dermatitis ◽

Microbial Diversity ◽

Controlled Trial ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

N/A

Download Full-text

26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.402 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB96

Author(s):

David Rosmarin ◽

Scott Fretzin ◽

Lindsay Strowd ◽

Marta Casillas ◽

Amy DeLozier ◽

...

Keyword(s):

Quality Of Life ◽

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Rapid Improvement ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies

The Journal of Headache and Pain ◽

10.1186/s10194-018-0951-2 ◽

2018 ◽

Vol 19 (1) ◽

Author(s):

Stefanie Förderreuther ◽

Qi Zhang ◽

Virginia L. Stauffer ◽

Sheena K. Aurora ◽

Miguel J. A. Láinez

Keyword(s):

Chronic Migraine ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Persistent Data ◽

Preventive Effects

Download Full-text

Poster 312 Muscle Selection Patterns for Injection of OnabotulinumtoxinA in Adult Patients with Post-Stroke Lower-Limb Spasticity Influence Outcome: Results from a Double-Blind, Placebo-Controlled Phase 3 Clinical Trial

PM&R ◽

10.1016/j.pmrj.2016.07.482 ◽

2016 ◽

Vol 8 (9) ◽

pp. S262

Author(s):

Alberto Esquenazi ◽

Carolyn Geis ◽

Theodore Wein ◽

Anthony B. Ward ◽

Chengcheng Liu ◽

...

Keyword(s):

Clinical Trial ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Stroke ◽

Limb Spasticity ◽

Lower Limb Spasticity

Download Full-text